Pages that link to "Q35847085"
Jump to navigation
Jump to search
The following pages link to Brain-derived neurotrophic factor and neuropsychiatric disorders (Q35847085):
Displaying 50 items.
- Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants (Q21129276) (← links)
- Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms (Q21131050) (← links)
- Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder (Q24626017) (← links)
- Epigenetic Modifications of Major Depressive Disorder (Q26741418) (← links)
- Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation? (Q26750898) (← links)
- Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteins (Q26750915) (← links)
- Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior (Q26766519) (← links)
- Omental transplantation for neuroendocrinological disorders (Q26782861) (← links)
- Antidepressant mechanism of ketamine: perspective from preclinical studies (Q26800231) (← links)
- Antidepressant actions of ketamine: from molecular mechanisms to clinical practice (Q26995879) (← links)
- From psychiatric disorders to animal models: a bidirectional and dimensional approach (Q26996269) (← links)
- Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date (Q27004490) (← links)
- BDNF deregulation in Rett syndrome (Q27005901) (← links)
- The neurobiological bases of memory formation: from physiological conditions to psychopathology (Q27027770) (← links)
- Hypermethylation of BDNF and SST Genes in the Orbital Frontal Cortex of Older Individuals: A Putative Mechanism for Declining Gene Expression with Age. (Q27310968) (← links)
- Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice (Q27327213) (← links)
- Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation (Q27332107) (← links)
- Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder (Q27335060) (← links)
- Corticostriatal BDNF and alcohol addiction (Q28083756) (← links)
- Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate (Q28276049) (← links)
- Association between BDNF gene polymorphisms and serotonergic activity using loudness dependence of auditory evoked potentials in healthy subjects (Q28486109) (← links)
- Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents (Q28822571) (← links)
- Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus. (Q30363005) (← links)
- Developmental vitamin D deficiency and schizophrenia: the role of animal models. (Q30366744) (← links)
- 'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue. (Q30385053) (← links)
- Post-traumatic stress disorder risk and brain-derived neurotrophic factor Val66Met (Q30387775) (← links)
- Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice (Q30416726) (← links)
- Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models (Q30416883) (← links)
- Low-intensity repetitive transcranial magnetic stimulation improves abnormal visual cortical circuit topography and upregulates BDNF in mice (Q30419265) (← links)
- An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice (Q30448071) (← links)
- Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (Q30594357) (← links)
- Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk (Q30650490) (← links)
- Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs (Q30659307) (← links)
- Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders (Q30680866) (← links)
- Transient anhedonia phenotype and altered circadian timing of behaviour during night-time dim light exposure in Per3-/- mice, but not wildtype mice. (Q30834441) (← links)
- Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons (Q30836800) (← links)
- Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive Disorder (Q33620401) (← links)
- Brain-Derived Neurotrophic Factor Mediated Perfluorooctane Sulfonate Induced-Neurotoxicity via Epigenetics Regulation in SK-N-SH Cells. (Q33625022) (← links)
- Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes (Q33647511) (← links)
- Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder (Q33655590) (← links)
- Neurobiology of local and intercellular BDNF signaling (Q33708741) (← links)
- The Evidence for Altered BDNF Expression in the Brain of Rats Reared or Housed in Social Isolation: A Systematic Review (Q33741366) (← links)
- Chronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscaling (Q33879254) (← links)
- Psychotropic Medications and Their Effect on Brain Volumes in Childhood Psychopathology (Q33888625) (← links)
- Rapamycin and interleukin-1β impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy (Q33947048) (← links)
- Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned? (Q34284039) (← links)
- Epigenetics, microRNA, and addiction. (Q34426201) (← links)
- The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. (Q34469404) (← links)
- Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women? (Q34482471) (← links)
- BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms (Q34499572) (← links)